Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 5 | 2016 | 96 | 0.780 |
Why?
|
| Hypoxia | 4 | 2016 | 115 | 0.750 |
Why?
|
| Vasoconstriction | 3 | 2016 | 22 | 0.640 |
Why?
|
| Nitric Oxide | 6 | 2016 | 174 | 0.600 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2015 | 29 | 0.580 |
Why?
|
| Lung | 5 | 2017 | 952 | 0.480 |
Why?
|
| Hemoglobins | 2 | 2015 | 135 | 0.480 |
Why?
|
| Vascular Resistance | 2 | 2016 | 48 | 0.430 |
Why?
|
| Erythrocyte Transfusion | 4 | 2016 | 74 | 0.410 |
Why?
|
| Epoxide Hydrolases | 2 | 2016 | 6 | 0.250 |
Why?
|
| Pulmonary Artery | 2 | 2016 | 95 | 0.230 |
Why?
|
| Shock, Hemorrhagic | 2 | 2013 | 20 | 0.210 |
Why?
|
| Tissue Scaffolds | 2 | 2017 | 84 | 0.150 |
Why?
|
| Arterial Pressure | 2 | 2016 | 27 | 0.150 |
Why?
|
| Erythrocytes | 2 | 2016 | 149 | 0.150 |
Why?
|
| Bioengineering | 1 | 2017 | 5 | 0.140 |
Why?
|
| Animals | 11 | 2017 | 20610 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 139 | 0.130 |
Why?
|
| Tricarboxylic Acids | 1 | 2016 | 2 | 0.130 |
Why?
|
| Trachea | 1 | 2016 | 84 | 0.130 |
Why?
|
| Materials Testing | 1 | 2016 | 84 | 0.130 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 147 | 0.130 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2016 | 7 | 0.120 |
Why?
|
| Purines | 1 | 2016 | 42 | 0.120 |
Why?
|
| Bioprosthesis | 1 | 2016 | 42 | 0.120 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2015 | 2 | 0.120 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2015 | 7 | 0.120 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 49 | 0.120 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 26 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2017 | 389 | 0.120 |
Why?
|
| Arginine | 1 | 2016 | 124 | 0.120 |
Why?
|
| Time Factors | 4 | 2016 | 3754 | 0.120 |
Why?
|
| Tissue Engineering | 1 | 2016 | 141 | 0.120 |
Why?
|
| Mice | 5 | 2016 | 10816 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 131 | 0.110 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2013 | 7 | 0.100 |
Why?
|
| Resuscitation | 1 | 2013 | 67 | 0.100 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2013 | 29 | 0.100 |
Why?
|
| Genotype | 1 | 2015 | 664 | 0.100 |
Why?
|
| Nitric Oxide Synthase | 1 | 2013 | 47 | 0.100 |
Why?
|
| Superoxides | 1 | 2013 | 71 | 0.100 |
Why?
|
| Thoracotomy | 1 | 2013 | 46 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2016 | 1536 | 0.100 |
Why?
|
| Stents | 1 | 2016 | 489 | 0.100 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 70 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 3387 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2013 | 199 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 175 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2013 | 608 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2179 | 0.090 |
Why?
|
| Phenotype | 1 | 2015 | 1199 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2013 | 509 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2015 | 2107 | 0.080 |
Why?
|
| Male | 5 | 2016 | 29717 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2016 | 248 | 0.050 |
Why?
|
| Sheep, Domestic | 2 | 2013 | 13 | 0.050 |
Why?
|
| Administration, Inhalation | 2 | 2012 | 151 | 0.050 |
Why?
|
| Biomarkers | 2 | 2017 | 1393 | 0.040 |
Why?
|
| Microvessels | 1 | 2017 | 19 | 0.040 |
Why?
|
| Endoderm | 1 | 2017 | 47 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2016 | 34 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 2016 | 34 | 0.030 |
Why?
|
| Female | 2 | 2016 | 32709 | 0.030 |
Why?
|
| Solubility | 1 | 2016 | 179 | 0.030 |
Why?
|
| Sheep | 1 | 2016 | 179 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 185 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 619 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 2016 | 27 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 307 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2016 | 147 | 0.030 |
Why?
|
| Oxygen | 1 | 2016 | 315 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2013 | 28 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 625 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 980 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2013 | 117 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 2036 | 0.030 |
Why?
|
| Peroxidase | 1 | 2013 | 71 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2152 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 1 | 2012 | 8 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 290 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 325 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 1977 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 934 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 236 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 1645 | 0.020 |
Why?
|
| Neutrophils | 1 | 2013 | 376 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1614 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 846 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 837 | 0.020 |
Why?
|
| Humans | 4 | 2017 | 63152 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 14333 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 16736 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 17480 | 0.010 |
Why?
|